Our Services
Medical Information
Helpful Resources
Published on: 9/29/2026
Calming someone with dementia at night often starts with reducing overstimulation: dim harsh lights, lower noise, limit caffeine and late-day naps, and keep a predictable bedtime routine so evening agitation, known as sundowning, has less room to build. Gentle reassurance, a calm tone, familiar music, a nightlight to ease shadows and confusion, and redirecting rather than correcting can settle distress faster than reasoning or arguing. Pain, infection such as a UTI, dehydration, constipation, medication timing and undiagnosed sleep apnea are common hidden triggers that make nighttime restlessness worse, and each is treatable. There are several factors to consider, including when nighttime behavior changes signal a medical problem rather than dementia progression, so review the complete details below before settling on a plan.
If you are unsure whether restlessness, confusion or a sudden change in behavior points to something treatable, a free, instant, online symptom check takes only a few minutes, asks the questions a clinician would ask, and helps you decide whether to call the care team now or monitor at home tonight.
Last reviewed for medical accuracy: 09/29/2026
Caring for a loved one with dementia can be especially challenging after dark. Disrupted sleep patterns, confusion and anxiety often intensify in the evening hours—a phenomenon known as “sundowning.” This guide offers practical, evidence-based strategies to help you create a calmer nighttime environment and support restful sleep for someone with dementia.
Dementia affects the brain’s internal clock, making it hard to distinguish day from night. Common issues include:
Recognizing these patterns can help you anticipate challenges and take preventive steps.
A soothing, safe space lays the foundation for better sleep. Consider the following adjustments:
Consistency and predictability can reduce anxiety at night. A calming pre-bed routine might include:
When agitation or confusion flares in the evening, try these approaches:
Building more structure and activity into the daytime can reduce nighttime restlessness:
Certain medications and health conditions can interfere with sleep. Work closely with your loved one’s healthcare provider to:
If you notice worsening symptoms or new concerns, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help guide your next steps.
Persistent sleep disturbances and severe agitation may need expert intervention:
Supporting someone with dementia at night can take an emotional and physical toll. Remember to:
Nighttime challenges in dementia care are common but manageable with patience, planning and teamwork. By creating a calm environment, sticking to consistent routines and staying attuned to health changes, you can help your loved one—and yourself—enjoy safer, more restful nights.
If you notice any serious or life-threatening symptoms, or if sleep and behavior issues become unmanageable, speak to a doctor right away. Your healthcare team can offer personalized guidance and interventions to keep your loved one safe and comfortable.
(References)
* Marinheiro G, Dantas JM, Mutarelli A, Menegaz de Almeida A, Monteiro GA, Zerlotto DS, Telles JPM. Efficacy and safety of brexpiprazole for the treatment of agitation in Alzheimer's disease: a meta-analysis of randomized controlled trials. Neurol Sci. 2024 Oct;45(10):4679-4686. doi: 10.1007/s10072-024-07576-8. Epub 2024 May 20. PMID: 38763935.
* Stroud J, Cummings JL, Chumki SR, Such P, Wang D, Palma AM, Zhang Z, Brubaker M, Grossberg GT. Brexpiprazole for agitation in clinically relevant patient subgroups: a post hoc analysis of efficacy and safety in patients with agitation associated with dementia due to Alzheimer's disease. Curr Med Res Opin. 2025 Aug;41(8):1523-1534. doi: 10.1080/03007995.2025.2552278. Epub 2025 Sep 5. PMID: 40847656; PMCID: PMC13559474.
* Behl S, Slomkowski M, Chen D, Chang D, Hefting N, Lee D, Shah A, Estilo A, Kalu U, Hobart M. Brexpiprazole for the treatment of agitation associated with dementia due to Alzheimer's disease: A 12-week, active-treatment, extension trial. J Alzheimers Dis. 2024 Nov;102(2):520-529. doi: 10.3233/JAD-240491. Epub 2024 Nov 13. PMID: 39534972.
* Davies SJ, Burhan AM, Kim D, Gerretsen P, Graff-Guerrero A, Woo VL, Kumar S, Colman S, Pollock BG, Mulsant BH, Rajji TK. Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia. J Psychopharmacol. 2018 May;32(5):509-523. doi: 10.1177/0269881117744996. Epub 2018 Jan 17. PMID: 29338602; PMCID: PMC5944080.
* Devanand DP, Crocco E, Forester BP, Husain MM, Lee S, Vahia IV, Andrews H, Simon-Pearson L, Imran N, Luca L, Huey ED, Deliyannides DA, Pelton GH. Low Dose Lithium Treatment of Behavioral Complications in Alzheimer's Disease: Lit-AD Randomized Clinical Trial. Am J Geriatr Psychiatry. 2022 Jan;30(1):32-42. doi: 10.1016/j.jagp.2021.04.014. Epub 2021 May 12. PMID: 34059401; PMCID: PMC8586042.
* Montano CB, Chumki SR, Wang D, Palma AM, Zhang Z, Porsteinsson AP. Brexpiprazole With Antidepressants for Agitation in Alzheimer's Dementia: Post Hoc Analysis. Am J Geriatr Psychiatry. 2026 Nov;34(11):1469-1476. doi: 10.1016/j.jagp.2026.06.015. Epub 2026 Jun 30. PMID: 42502037.
* Grossberg GT, Sabbagh MN, Chumki SR, Wang D, Such P, Zhang Z, Palma AM, Cummings JL. Efficacy of Brexpiprazole on Neuropsychiatric Symptoms and Impact on Caregivers: Pooled Neuropsychiatric Inventory (NPI) Analysis in Patients With Agitation Associated With Dementia due to Alzheimer's Disease. J Geriatr Psychiatry Neurol. 2026 Sep;39(5):589-601. doi: 10.1177/08919887251407124. Epub 2025 Dec 24. PMID: 41439450; PMCID: PMC13320130.
* Brusco LI, Fainstein I, Márquez M, Cardinali DP. Effect of melatonin in selected populations of sleep-disturbed patients. Biol Signals Recept. 1999 Jan-Apr;8(1-2):126-31. doi: 10.1159/000014580. PMID: 10085474.
* Sarangal M, Sarangal C, Vora J, Soni K. Auvelity (Dextromethorphan-Bupropion) for Agitation and Aggression in Alzheimer's Disease Dementia: Mechanism, Efficacy, Safety, and Clinical Considerations. Psychopharmacol Bull. 2026 Sep 18;56(4 Suppl 1):82-87. doi: 10.64719/pb.20773. PMID: 42763636; PMCID: PMC13589235.
* Mouriz-Corbelle R, Caamaño-Ponte J, Dosil C, Picón E, Facal D. Apathy and agitation in institutionalized older adults: an empirically derived classification. Psychogeriatrics. 2021 May;21(3):272-278. doi: 10.1111/psyg.12659. Epub 2021 Feb 17. PMID: 33598981.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.